# LPR-DIR-017 — Executive Review (Phase 6)

An executive synthesis of Phases 1–5 for LumenAI Version 1.0 RC1. Baseline `bd94bc5`.

## Strengths
- **Coherent, frozen, test-verified architecture** — governed inspection pipeline;
  single hash-chained audit writer; tenant-membership authority; AI strictly inside
  human authority.
- **Strong engineering quality** — avg complexity A(3.34), lint-clean, 0 TODO/FIXME,
  **3,696 tests / 8,404 assertions**, 0 hidden Critical debt.
- **Sound security architecture** — zero-trust OIDC/JWKS auth, default-deny (1,593
  guards), immutable tamper-evident audit + evidence, **0 CVEs**, SBOM.
- **Proven recovery** — DR **executed with measured RTO 10.4 s** and provable
  integrity-after-recovery.
- **Honesty posture** — deterministic inference self-labeled "not a trained CV
  model"; **no diagnostic/clinical/regulatory claim**; no Critical finding hidden or
  downgraded across six phases.
- **Substantial operational documentation** — CI gates, runbooks, Prometheus/Grafana,
  versioned GHCR release.

## Weaknesses
- **Secure-by-default not fully met** — insecure secret fallback defaults + no
  fail-closed startup validation → 1 CRITICAL + 2 HIGH.
- **Production-scale operation unproven** — no load test; single-Postgres SPOF;
  single-worker pods; in-process scheduler duplication.
- **Immature operational processes** — no incident-response/on-call/alerting;
  un-wired production deploy; no rollback drill.
- **Observability depth** — thin metrics; no latency histograms/tracing/alerts.
- **Localized maintainability debt** — one 10.5 kLOC god-module; helper duplication.

## Outstanding work (to reach production)
Close 1 CRITICAL + 8 HIGH: webhook fail-closed + startup secret validation; run the
load test + provision HA Postgres + multi-worker; scheduler leader-election; stand up
incident-response + alerting + on-call; wire + drill deploy/rollback. Then MEDIUM
hardening (audit atomicity, dataset-freeze, dedup, god-module decomposition, config,
CI pinning, observability depth, governance processes, runbook reconciliation, IaC
consolidation).

## Release risks
The dominant release risk is **cross-tenant data injection (SEC-C-01)** — a
multi-tenant clinical-adjacent platform must not ship this. Secondary: unmeasured
production behavior (load/HA) and inability to detect/respond to incidents.

## Operational risks
Single-DB SPOF, in-process scheduler duplication, un-drilled deploy/rollback, no
alerting/on-call — the org **cannot yet operate the platform unattended in
production**, but **can** run a **supervised pilot** with humans in the loop
(consistent with Pilot Alpha / Directive 010 GO WITH CONDITIONS).

## Future roadmap (post-conditions, not V2 planning)
1. **Hardening cycle** — close the CRITICAL + HIGH blocking set.
2. **Production readiness re-test** — re-run security + a real load/stress test; HA +
   observability + incident process stand-up; deploy/rollback drills.
3. **Governed model track** — a certified CV model + clinical validation remains a
   future, separately-governed program (no diagnostic claim today).

## Executive conclusion
LumenAI v1.0 is **engineering-complete and architecturally certified**, with an
honest, evidence-backed readiness posture. It is **not production-authorizable today**
due to 1 CRITICAL + 8 HIGH conditions, all pre-existing, tracked, and remediable
without redesign. The right executive action is to **certify RC1 as a frozen baseline
for a focused hardening cycle** — **GO WITH CONDITIONS** — with production and
clinical deployment firmly withheld.
